ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Disruption of upstream ox-LDL signaling and HSP90-mediated NLRP3 stability protects against experimental steatohepatitis.
Alaa Karam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.